Search clinical trials for: complete pathological response

Total 26059 results

GlaxoSmithKline

Active, not recruiting

Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-1)

Nasal Polyps

United States, Argentina, France, Netherlands, Spain, Germany, Belgium, China, United Kingdom, Japan, Canada
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer

Breast Cancer

United States
Sun Yat-sen University

Active, not recruiting

TNT to Increase the Clinical Complete Response Rate for Distal LARC (TESS)

Chemoradiation | Rectal Cancer | Rectal Cancer Stage II | Rectal Cancer Stage III

China
Sun Yat-sen University
First Affiliated Hospital, Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital...

Active, not recruiting

ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC

Breast Cancer | Neoadjuvant Chemotherapy

China
Galderma R&D

Terminated

A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

Keratosis, Actinic

United States, Puerto Rico
Satish R. Raj
National Center for Advancing Translational Sciences (NCATS)

Active, not recruiting

Treatment of Orthostatic Intolerance

Tachycardia | Chronic Orthostatic Intolerance

United States
Armando Giuliano

Withdrawn

Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response

Breast Cancer | HER2-positive Breast Cancer

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Radiomics-based Models for the Prediction of Pathological Response to Neoadjuvant Therapy in Gastric and Gastroesophageal Cancer (RADI-S)

Patients With Locally Advanced Carcinoma of the Stomach and Oesophagogastric Junction
ppharmaand GmbH
Bristol-Myers Squibb; Gynecologic Oncology Group; European Network of Gynaecological... and other collaborators

Active, not recruiting

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA)

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response

United States, United Kingdom, Korea, Republic of, Russian Federation, Canada, Denmark, Taiwan, New Zealand, Ireland, Japan, Spain, Australia, Israel, Italy, Greece, Sweden, Czechia, Finland, Poland, Belgium, Germany, Romania, Singa... and more
Ospedale Policlinico San Martino
CRO "Centro Clinical Trials" IRCCS Ospedale Policlinico San Martino; Laboratory...

Withdrawn

Niraparib Maintenance Treatment in mCRC With a Partial o Complete Response After Oxaliplatin-based Induction Therapy (Bohème)

Metastatic Colorectal Cancer
Merck Sharp & Dohme LLC

Active, not recruiting

Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

Hepatocellular Carcinoma

United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Denmark, France, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, New Zealand, Norway, Poland, Russian Federation, Spai... and more
Melanoma Institute Australia
Merck Sharp & Dohme LLC; Novartis

Active, not recruiting

Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma (Neo Trio)

Melanoma

Australia
Rawalpindi Medical College

Completed

Neoadjuvant Therapy With Trastuzumab and Chemotherapy and the Resultant Pathologic Complete Response Observed in HER2 Positive Breast Cancer;a Systematic Review

HER2+ Breast Cancer

Pakistan
AbbVie

Completed

A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs (SELECTSUNRISE)

Rheumatoid Arthritis

Japan
University Hospital, Ghent

Completed

Inception, Validation and Clinical Utility of a Score to Assess the Completeness of Caecal Visualisation

Colorectal Cancer | Colonic Polyp

Belgium
Yuan-hong Gao
Fujian Cancer Hospital; Tongji Hospital; Peking University Cancer Hospital &... and other collaborators

Completed

Treatment Strategy for Rectal Cancer Patients With Complete Clinical Response

Rectal Cancer | Organ Preservation

China
Cancer Trials Ireland

Terminated

CharactHer. ICORG 12-09, V3

HER2-positive Breast Cancer | TNM Stage II-IV Breast Cancer

Ireland, Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Active, not recruiting

PIK3CA in HER2+ BC and pCR Trial

HER2-positive Breast Cancer

Italy
Peking Union Medical College Hospital

Completed

Pilot Study of Tocilizumab Monotherapy for Active Chronic Periaortitis

Chronic Periaortitis | Tocilizumab Monotherapy

China
AbbVie

Completed

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent). (VENICE II)

Chronic Lymphocytic Leukemia (CLL)

Argentina, Australia, Bulgaria, Hong Kong, Hungary, Mexico, New Zealand, Poland, Russian Federation, Taiwan
National Cancer Institute (NCI)

Completed

Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma

Mantle Cell Lymphoma | Lymphoma, Mantle Cell

United States
Xenikos
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Terminated

A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) (2002)

Steroid-Refractory Acute Graft Versus Host Disease

United States, Belgium, Croatia, France, Germany, Italy, Netherlands, Spain, United Kingdom
Galderma R&D

Completed

Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma

Basal Cell Carcinoma

Australia
University Hospital, Ghent
Nobel Biocare

Completed

Immediate Load of Dental Implants, Placed in Atrophic Upper and/or Lower Jaw of Partial or Complete Edentate Patients, According to Flapless Technique

Dental Implants

Belgium
Sohag University

Active, not recruiting

Comparison Between Results of 2 Laparoscopic Surgical Procedures in Operable Colon Cancer Cases in Upper Egypt

Colon Cancer Stage II | Colon Cancer Stage I

Egypt
Guangdong Provincial People's Hospital

Completed

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

Chemotherapy | Non Small Cell Lung Cancer | Immunotherapy | Tumour, Residual

China
Mayo Clinic

Withdrawn

Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma

Hodgkin Lymphoma | Stage III Adult Hodgkin Lymphoma | Stage IV Adult Hodgkin Lymphoma | Stage I Adult Hodgkin Lymphoma | Stage II Adult Hodgkin Lymphoma

United States
Avicenna Military Hospital

Completed

Segmental Spinal Anesthesia for Small-incision Cholecystectomy in a Field Hospital (SPICHOL)

Anesthesia | Gall Stones (& [Calculus - Gall Bladder])
Bristol-Myers Squibb
PPD; European Organisation for Research and Treatment of Cancer - EORTC; ICON... and other collaborators

Completed

Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response (DASFREE)

Chronic Phase Chronic Myeloid Leukemia

United States, Canada, France, Germany, Italy, Spain
University of California, Irvine
Beckman Laser Institute University of California Irvine

Withdrawn

Predicting Pathological Response Within the 1st Week of Chemotherapy Using Diffuse Optical Spectroscopic Imaging

Breast Cancer

United States
Royal North Shore Hospital

Completed

Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET (PRISM)

Rectal Neoplasms

Australia
The Adelaide and Meath Hospital, incorporating...

Withdrawn

Percutaneous Nephrostomy Versus Stent In Sepsis Trial (PERSIST)

Sepsis | Hydronephrosis | Ureteric Calculus

Ireland
Centre Hospitalier Universitaire de Nīmes

Completed

Assessment of Complete Response MRI Criterion After Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Rectal Neoplasms

France
Sohag University

Completed

Trans-nasal Complete Nasolabial Cyst Excision

Nasolabial Cyst

Egypt
Sixth Affiliated Hospital, Sun Yat-sen University

Completed

TRUS-FNA For The Prediction Of pCR After Neoadjuvant Treatment In Rectal Cancer

Rectal Cancer | EUS-FNA | Pathological Complete Remission

China
Mian XI

Completed

Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer

Unresectable Esophageal Cancer

China
University Hospital, Bordeaux

Completed

Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2) (NiloPost-STIM)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

France
Hospital San Carlos, Madrid

Completed

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

Rectal Cancer Stage II | Rectal Cancer Stage III | Rectal Cancer, Adenocarcinoma | Distant Metastasis | Local Recurrence of Malignant Tumor of Rectum

Spain
National Institute of Diabetes and Digestive and...

Completed

Interaction of Cobalamin Status With Nitrous Oxide in Relation to Postoperative Cognitive Changes in the Elderly

Avitaminosis | Delirium, Dementia, Amnestic, Cognitive Disorders

United States
Albert B. Sabin Vaccine Institute
ICON plc; Oklahoma Blood Institute

Completed

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Ebola Virus Disease | Marburg Virus Disease

United States
Cardio Med Medical Center
George Emil Palade University of Medicine, Pharmacy, Sciences and Technology... and other collaborators

Completed

Inflammation-mediated Coronary Plaque Vulnerability, Myocardial Viability and Ventricular Remodeling (VIABILITY)

Heart Failure | Acute Myocardial Infarction

Romania
Nazmy Edward Seif

Completed

U/S-guided Continuous Quadratus Lumborum Block III in Percutaneous Nephrolithotomy

Analgesia | Surgery | Renal Stone

Egypt
Genzyme, a Sanofi Company

Completed

Phase 3b Study to Evaluate Skeletal Response to Eliglustat in Adult Patients Who Completed Phase 2 or Phase 3 Studies (EXOSKEL)

Gaucher Disease

Canada, Russian Federation, Tunisia
United States Army Research Institute of Environmental...
University of Arkansas; Norwegian Defense Research Establishment

Completed

Physiological Response to Protein and Energy-enhanced Food Products During Winter Military Training

Weight Loss | Military Operational Stress Reaction | Malnutrition (Calorie) | Muscle Wasting

Norway
B.P. Koirala Institute of Health Sciences

Completed

Effects of Morphine Added to Bupivacaine in Transversus Abdominis Plane Block for Inguinal Hernia Repair

Inguinal Hernia

Nepal
Indiana University

Completed

Dose-response Effect of Dietary Nitrate on Muscle Function in Older Individuals

Sarcopenia | Aging

United States
Hartford Hospital
University of Maryland; University of Connecticut

Completed

Vaginal Probiotics and Pessaries and Their Impact on the Vaginal Microenvironment

Inflammatory Response | Pelvic Organ Prolapse | Dysbiosis

United States
Lahore General Hospital

Active, not recruiting

Booster Effect of mRNA Vaccine on Antibody Response for SARS-CoV-2 After Complete Vaccination With Sinos

Vaccine Reaction

Pakistan
University Hospital, Bordeaux

Completed

Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response (HSYNC)

Hypertrophic Cardiomyopathy | Mechanical Hyper-synchronicity

France
Organon and Co

Completed

A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)

Fertilization

Search clinical trials for: complete pathological response

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations